Press release
Viscosupplementation Market Size to Boost USD 10.51 Billion By 2032 | CAGR 9.1% - Published by Emergen Research
Viscosupplementation Market
The Viscosupplementation market is witnessing significant growth, driven by several factors that are reshaping the landscape of this segment of the healthcare industry. Viscosupplementation, a minimally invasive procedure involving the injection of a gel-like fluid into joints to provide lubrication and cushioning, has gained prominence as a treatment for osteoarthritis, particularly in the knee. As the global population ages and the prevalence of osteoarthritis continues to rise, the demand for viscosupplementation products and procedures is expected to increase steadily over the coming years.
The report offers these individuals a vivid description of the competitive spectrum of the global Viscosupplementation Market The study audits various winning strategies adopted by the market leaders to maintain the competitive edge worldwide. This adds more clarity to the research. Resource charts, tables and graphical images are included to make decisive statistics self-explanatory.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/2773
Drivers of the Viscosupplementation Market :
Several key drivers are fueling the expansion of the Viscosupplementation market. Firstly, the growing aging population worldwide is a primary driver, as older individuals are more susceptible to osteoarthritis and related joint issues. Additionally, rising awareness among both patients and healthcare professionals about the benefits of viscosupplementation in managing osteoarthritis pain and improving joint function is driving greater adoption of these procedures. Moreover, technological advancements in viscosupplementation products, such as the development of longer-lasting and more effective formulations, are enhancing patient outcomes and expanding the market's potential.
Growth Factors of the Viscosupplementation Market :
Several growth factors are contributing to the expansion of the Viscosupplementation market. One significant factor is the increasing preference for non-surgical treatment options among patients, particularly those who wish to avoid or delay joint replacement surgery. Viscosupplementation offers a less invasive alternative for managing osteoarthritis symptoms and improving mobility, making it an attractive option for many individuals. Additionally, the growing emphasis on personalized medicine and tailored treatment approaches is driving the development of innovative viscosupplementation products that cater to the specific needs of patients.
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/2773
The report also discusses the key players involved in the market such as:
Sanofi, F. Hoffmann-La Roche Ltd, Anika Therapeutics, Inc., Zimmer Biomet., Bioventus, Fidia Farmaceutici S.p.A., SEIKAGAKU CORPORATION, Chugai Pharmaceutical Co., Ltd., OrthogenRx, Inc., Miravo Healthcare, APTISSEN, LG Chem, AVNS, Smith+Nephew, Lifecore Biomedical, Inc., Medical Device Business Services, Inc., Wellchem Pharmaceuticals Pte Ltd., Teva Pharmaceutical Industries Ltd., Labrha International, and Ferring B.V.
The report provides a thorough estimation of the overall impact of the pandemic on the Viscosupplementation Market and its vital segments. The report also discusses the impact of the pandemic across different regions of the market. It also offers a current and future assessment of the impact of the pandemic on the Viscosupplementation Market
Viscosupplementation Latest Industry Updates
On 17 September 2023, KiOmed Pharma and Arsylab, a French biotechnology company specializing in the design and marketing of innovative products to improve patients' quality of life, announced the strategic collaboration to enter the French market for promotion and distribution of KioMedineone, a new class of knee osteoarthritis treatment.
On 19 September 2022, Alkem Laboratories announced the regulatory approval of federal agency the Drug Controller General of India (DCGI) for the launch of StemOne, designated for treatment of Knee Osteoarthritis (OA) in collaboration with Stempeutics in India.
Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/2773
Viscosupplementation Market Segment Analysis :
For the purpose of this report, Emergen Research has segmented the global viscosupplementation market on the basis of dosage type, application, source, end-use, and region:
Dosage Type Outlook (Revenue, USD Billion; 2019-2032)
Single Injection
Three Injection
Five Injection
Application Outlook (Revenue, USD Billion; 2019-2032)
Knee Osteoarthritis
Hip Osteoarthritis
Hand/ Wrist Osteoarthritis
Ankle/ Foot Osteoarthritis
Shoulder Osteoarthritis
Others
Source Outlook (Revenue, USD Billion; 2019-2032)
Animal
Non-animal
End-use Outlook (Revenue, USD Billion; 2019-2032)
Hospitals
Orthopedic Clinics
Ambulatory Surgical Centers (ASCs)
Others
Regional Outlook (Revenue, USD Billion; 2019-2032)
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Benelux
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of Middle East & Africa
Browse Full Report Description + Research Methodology + Table of Content + Infographics @ https://www.emergenresearch.com/industry-report/viscosupplementation-market
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Viscosupplementation Market Size to Boost USD 10.51 Billion By 2032 | CAGR 9.1% - Published by Emergen Research here
News-ID: 3472659 • Views: …
More Releases from Emergen Research
Global Internet of Things (IoT) in Healthcare Market to Reach USD 299.05 Billion …
The global Internet of Things (IoT) in Healthcare Market was valued at USD 299.05 billion in 2023 and is expected to grow at a CAGR of 16.5% during the forecast period. This growth is fueled by the rising use of connected healthcare devices, increasing demand for early disease detection through remote monitoring, and growing adoption of artificial intelligence (AI) tools within IoT-based healthcare systems.
The market is also benefiting from the…
Global Stem Cell Therapy Market to Reach USD 49.2 Billion by 2034, Growing at 13 …
The global Stem Cell Therapy Market, valued at USD 13.7 billion in 2024, is projected to reach USD 49.2 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.6%. Growth is being fueled by the rising burden of chronic diseases, rapid progress in cell-based studies, and increasing investments in regenerative medicine and personalized healthcare solutions.
Stem cell therapies offer the ability to repair, replace, or restore damaged tissues…
Artificial Intelligence Strengthens Cybersecurity as Threats Grow More Sophistic …
The global Artificial Intelligence in cybersecurity market size was USD 23.8 Billion in 2023 and is expected to reach a market valuation of USD 29.44 billion by the end of 2024 registering a CAGR of 23.7% during the forecast period. The adoption of Artificial Intelligence (AI) in cybersecurity is rapidly gaining traction as organizations worldwide face increasingly complex and frequent cyber threats. By combining advanced technologies such as Machine Learning…
Global Regenerative Medicine Market to Reach USD 125.6 Billion by 2034, Growing …
The global regenerative medicine market, valued at USD 34.2 billion in 2024, is set to grow to USD 125.6 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.9%. Growth is being fueled by rising approvals of advanced therapies, strong demand for personalized treatments in cancer and orthopedics, and expanding cell and gene therapy manufacturing across major markets such as North America, Europe, and Asia.
Once seen as…
More Releases for Viscosupplementation
Viscosupplementation Market Report, History and Forecast 2023-2031
Newark, New Castle, USA - Growth Plus Reports has published a new report on Viscosupplementation Market, which includes a detailed analysis based on competitors and important market segments (2023-2031). The Global Viscosupplementation provides a thorough analysis of many segments such as opportunities, market size, developments, innovation, sales, and overall growth of leading players. The research is based on primary and secondary statistical data, and it includes both intuitive and statistical…
Hampering the growth of the viscosupplementation market 2021
Viscosupplementation is a minimally invasive procedure that involves injection of the hyaluronic acid injected into a knee joint to promote better joint development and lubrication. It also helps in reducing pain, irritation and helps in improving osteoarthritis condition. Hyaluronic acid (HA) or hyaluronate is a non-sulfated glycosaminoglycan that is distributed throughout the body in epithelial, connective tissues, and neural tissues. Increasing prevalence of osteoarthritis in people is expected to boost…
Understanding Impact of COVID-19 on Viscosupplementation Market
According to the report, the global viscosupplementation market was valued at ~US$ 2.6 Bn in 2018 and is projected to expand at a CAGR of ~7% from 2019 to 2027. Viscosupplementation can be performed using three primary injection types: single injection, three injections, and five injections. Applications of viscosupplementation injection include knee osteoarthritis, hip osteoarthritis, and hand osteoarthritis. Growth of the global viscosupplementation market can be attributed to rise in…
The three injection viscosupplementation product type segment is projected to be …
Russia’s healthcare infrastructure will continue witnessing significant rise in number of orthopaedic patients as several bone & joint-related disorders are likely to be caused by people’s eating & drink habits, their proactive lifestyles and the country’s harsh weather conditions. Rising occurrence of joint-related ailments such as knee osteoarthritis in Russia are a result of people performing physical labour in severely cold weather conditions. This has necessitated the adoption of viscosupplementation…
Viscosupplementation Market
The rising obesity rate, coupled with an increasing geriatric population in Russia is giving rise to an increasing number of cases of knee osteoarthritis. Prevalence of osteoarthritis in the adult population in Russia is approximately 13%. Knee osteoarthritis is causing disability in the ageing population and this is the precise reason for the rise in demand for viscosupplementation market. Considering this fact, a new market report titled “Viscosupplementation Market: Russia…
Viscosupplementation Market: Three Injection Viscosupplementation Likely to be t …
The rising obesity rate, coupled with an increasing geriatric population in Russia is giving rise to an increasing number of cases of knee osteoarthritis. Prevalence of osteoarthritis in the adult population in Russia is approximately 13%. Knee osteoarthritis is causing disability in the ageing population and this is the precise reason for the rise in demand for viscosupplementation market. Considering this fact, a new market report titled “Viscosupplementation Market: Russia…
